Avacta set for success


Diagnostics technology company has increased half-year revenues by 72% to £1.72 million over the period to 31 January 2012, reports TheBusinessDesk.com.

The University of Leeds spinout is in its strongest position since launch, according to Chief Executive Alastair Smith.

Mr Smith said,
"The business is fully funded and capable of exploiting substantial intellectual property in its own pipeline of technology and tests, and in the recently acquired Affimer reagent platform."

The company is close to shipping the first of its AX.1 test range units.

Read the full story here.



Related News

Copyright © 2014 Med-Tech Innovation
Submit Editorial | Media Kit | Privacy Policy | Terms of Service | Site map